|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/20 | (2006.01) |
| A61K 9/28 | (2006.01) | ||
| A61K 9/48 | (2006.01) | ||
| A61K 31/00 | (2006.01) |
| (11) | Number of the document | 3650016 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19217651.9 |
| Date of filing the European patent application | 2014-03-14 | |
| (97) | Date of publication of the European application | 2020-05-13 |
| (45) | Date of publication and mention of the grant of the patent | 2021-05-05 |
| (46) | Date of publication of the claims translation | 2021-09-27 |
| (30) | Number | Date | Country code |
| 201361801896 P | 2013-03-15 | US |
| (72) |
White, Jay A., CA
Melnick, Joel Z., US
Agudoawu, Sammy A., CA
Tabash, Samir P., CA
|
| (73) |
EirGen Pharma Ltd.,
Westside Business Park Old Kilmeaden Road, Waterford X91 YV67,
IE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Stabilizuota vitamino D vaistinė forma su modifikuotu atpalaidavimu ir jos vartojimo būdas |
| STABILIZED MODIFIED RELEASE VITAMIN D FORMULATION AND METHOD OF ADMINISTERING SAME |
| Payment date | Validity (years) | Amount | |
| 2026-02-18 | 13 | 289.00 EUR |
| 2027-03-14 |